A patient with acute on chronic liver failure

Size: px
Start display at page:

Download "A patient with acute on chronic liver failure"

Transcription

1 A patient with acute on chronic liver failure Dott.ssa Marta Cavallin Dept. of Medicine of University of Padova, Italy 6 th Post Meeting AISF Rome, 23 rd February 2013

2 Dott.ssa Marta Cavallin medico in formazione specialistica Dipartimento di Medicina dell Università di Padova Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d interesse in relazione a questa presentazione e che la presentazione non contiene discussione di farmaci in studio o ad uso off-label

3 A 57 years old male was admitted to our Unit of Hepatic Emergencies and Liver Transplantation in Padova on the 4 th of July 2012.

4 Medical case-history (1) Diagnosis of alcoholic cirrhosis in Medical Division in Valdagno where he was admitted for acute bronchitis in July 2011 Ex heavy smoker (3 cigarette packages per day for 16 years) Obesity since youth got worse in Actually body weight=120 Kg. Diagnosis of diabetes mellitus in 2003, treated with insulin In 2008 Malaria contracted in Mozambico that was treated for one month (follow up reported negative) Bleeding gastric ulcer in 2003 Operation for bilateral cataracts in 2004 Allergy to graminaceous plants

5 Medical case-history (2) Travel in China one month before with the appearence of iperchromatic urine. When he came back to Italy he had cough, scleral jaundice, emesis, no fever antibiotic therapy for suspected pneumonia On the 25th of June 2012, because of the persistence of scleral and skin jaundice he went to the PS and he was recovered in General Medicine jaundice in hepatic alcoholic cirrhosis During the staying in this hospital he developed: ACLF: treatment with steroid therapy (Solumedrol 40 mg/die ev), furosemide ev and from 29/6 with acetilcistein ev (4 fl ev/die) An episode of supraventricular tachycardia that was treated with amiodarone (1 cp da 200 mg/die)

6 What about the etiology of the hepatic disease (1)? No familarity for hepatic diseases No consumption of mussels or raw fish in the last month No sexual intercourses at risk No work in fields No usage of FANS or other hepatotoxic drugs No usage of products of herbalist s shop Personal history of diabetes (2003) treated with insulin therapy Obesity (2003) Active potus: consumption of about 1500 cc of wine every day and 3 liquors per week until the recovery Mild subclinic hypothyroidism (TSH = pmol/l, ft4 = pmol/l, ft3 = 2.58 miu/l)

7 What about the etiology of the hepatic disease (2)? Negativity of IgM HAV Negativity of HbsAg, anti-hbs e anti-hbc Negativity of Ac anti-hcv Negativity of HEV Ag and Ac anti-hev Negativity of IgM EBV and CMV Negativity of IgM anti-leptospira Negativity of Ac anti-transglutaminasi Negativity of ANA, AMA, SMA, anti-lkm, anti-sla, ANCA Normal ceruloplasmin (0.28 g/l) and cupremia (19 µmol/l) Normal sideremia (21.7 µmol/l), reduction of transferrin (0.83 g/l), transferrin saturation index (>100%), hyperferritinemia (1348 µg/l). Negativity of HEF genotype

8 Medical Examination Alert, cooperative, oriented S/T/P Cutaneous and scleral jaundice Widespread ecchymosis on superior limbs PA=140/70 mmhg, HR=108 bpm ar, SatO2=98% in aa. Heart: arrhythmical tones, no cardiac murmurs Chest: MV present, no pathologic sounds Abdomen: globose, not aching. Moderate ascites. Epatomegaly and splenomegaly. Peristalsis present. AAII: light bilateral edemas Ex. neurologic: Mingazzini I e II negative, no deficit of cranial nerves. No flapping tremor.

9 Baseline clinical and laboratory features (1) DATA Hb (g/dl) (v.n ) 11.7 WBC (x 10 9 /l) (v.n ) Piastrine (x 10 9 /l) (v.n ) 26 PCR (mg/l) (v.n. 0-6) 36 Serum total bilirubin (µmol/l) (v.n ) (31 mg/dl) Serum direct bilirubin (µmol/l) (v.n ) (24.84 mg/dl) Serum creatinine (µmol/l) (v.n ) 142 (1.56 mg/dl) Serum Na (mmol/l) (v.n ) 131 Serum K (mmol/l) (v.n ) 3.4 INR 1.75 Albumin (g/l) (v.n ) 32 Total serum proteins (g/l) (v.n ) 54.2

10 Baseline clinical and laboratory features (2) DATA Ammonia (µmol/l) (v.n ) 80 AST (U/L) (v.n ) 76 ALT (U/L) (v.n ) 69 GGT (U/L) (v.n. 3-65) 103 ALP (U/L) (v.n ) 145 MELD score 30 MELD Na score 32 CTP class (score) C (13)

11 Diagnostic procedures Rx chest (10/07): ndp EGDS (6/07): blu F1 esophageal varices, cardia incontinence, congestive gastropathy TC abdomen with contrast medium (6/7): no focal hepatic lesions... open spleno-mesenteric-portal axis... Epatosplenomegaly... moderate ascites

12 What about the management of this patient? Liver failure Bacterial and/or fungal infections Renal Failure Cardiovascular problems Valuation for liver transplant

13 Management of liver failure According to Lille criteria steroid therapy was stopped. We started treatment with PENTOXYFILLINE (400 mg three times a day) and parenteral nutrition. This therapy was continued until the 9th of Agoust.

14 Management of infections (1) negativity of nasal, perianal, rectal tampons urine cultures blood cultures

15 Management of infections (2) It was prescribed antibiotic therapy with CEFTAZIDIME (1 g x 2/die) and TEICOPLANINA (initial dose of 600 mg and then 400 mg every 2 days) according to the results of urine culture modifing the doses according to renal clearence.

16 Management of infections (3)

17 Management of infections (4)

18 Management of infections (5) patient piretic (T=38 C) Antibiotic therapy was modified with the introduction of MEROPENEM (1 g x 3 /die) and DAPTOMICINA (500 mg/die). It was also started therapy for fungi with CASPOFUNGINA (50 mg/die).

19 Management of infections (6).following blood and urine cultures were negative.. so on the 14 th of August antibiotic therapy was stopped.

20 Management of renal failure (1) Trend of serum creatinine (µmol/l) during the stay in hospital

21 Management of renal failure (2) Trend of proteinuria of 24 h during the stay of hospital

22 Management of renal failure (3) Serial episodes of worsening of renal failure, which was still present at admission, that were treated with temporary withdrawal of diuretics, plasma volume expansion with albumin or saline.

23 Management of cardiovascular problems One episode of circulatory overloaded with initial signs of left cardiac failure that was treated with diuretics. Episodes of ventricular tachycardia with an arrhythmical ECG evocative for Brugada s syndrome that were treated with K and Mg addition (however they were already in range but at medium-low levels). Patient was still having amiodarone.

24 Perspective of liver transplantation (LT) There were 2 issues in the perspective of LT: 1) toxicological issue: not favourable opinion considering the insufficient willing for toxicological monitoring, the not proved withdrawal out of hospital and the negative familiar context. 2) cardiovascular issue: not favourable opinion because it needed further valuation considering the complex cardiologic problem (arrhytmy and cardiovascular risk factors) including coronarography. It was not possible to do coronarography because of the continuous instability of renal function.

25 Evolution of the clinical picture (1).on the 17 th of August general conditions were improved. The severity of liver failure was progressively reducing (total bilirubin=202 µmol/l (11.7 mg/dl), dir. = 143 µmol/l (8.3 mg/dl), INR = 1.49). Infections were solved. There was still renal failure (final serum creatinine=175 µmol/l or 1.9 mg/dl) and the ascites was moderate. Patient followed an oral nutritional management with still a partial parenteral support (1000 ml/day of Oliclinomel n 5 with the addition of insulin). Glycaemia was well controlled with insulin.

26 Evolution of the clinical picture (2) 1. On the 17th of August 2012 he was moved to the General Medicine at the Hospital of Valdagno (VI). 2. The final diagnosis was: Acute on chronic liver failure due to alcohol-related cirrhosis (with also evidence for a metabolic component and iron overload), actually with ascites and renal failure (functional component over an organic component), several episodes of ventricular tachycardia (suspected Brugada s syndrome), obesity, diabetes mellitus in patient, actually, non suitable to liver transplant.

27 Evolution of the clinical picture (3) 17th of August- 18th of September 2012: stay in General Medicine in Valdagno (VI) with an improvement of general conditions (when he was discharged: tot.bilirubin=2.1 mg/dl, serum creatinine=2.17 mg/dl) 27th of September-17th of October: new admission to the hospital of Valdagno because of worsening of renal failure (serum creatinine=5.21 mg/dl). He had FANS for shoulder pain!.he was treated with diuretics. At the moment of discharge: creatinine=2.34 mg/dl, total bilirubin=7.4 mg/dl, INR= th of November: admission to the hospital of Valdagno because of an increase of weight of 14 Kg, worsening of renal function (serum creatinine=3.7 mg/dl), encephalopathy...

28 Evolution of the clinical picture (4)..hepatorenal syndrome treated with albumin and terlipressin and diuretics without response... Patient died on the 18th of November 2012

Filippo Schepis, MD Università degli Studi di Modena e Reggio Emilia

Filippo Schepis, MD Università degli Studi di Modena e Reggio Emilia Filippo Schepis, MD Università degli Studi di Modena e Reggio Emilia Il sottoscritto dichiara di non aver avuto/di aver avuto negli ultimi 12 mesi conflitto d interesse in relazione a questa presentazione

More information

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion 5 th AISF Post-Meeting Course Diagnostic and Therapeutic Invasive Procedures in Hepatology Rome, February 25 th Diagnostic Procedures Measurement of Hepatic venous pressure in management of cirrhosis Clinician

More information

Prototypes of autoimmune hepatitis and sclerosing cholangitis in childhood

Prototypes of autoimmune hepatitis and sclerosing cholangitis in childhood RIUNIONE MONOTEMATICA AISF 2013 Personalizzazione della Cura in Epatologia 17-19 ottobre 2013, PISA Prototypes of autoimmune hepatitis and sclerosing cholangitis in childhood La sottoscritta dichiara di

More information

Pazienti con Genotipo 1 e Cirrosi Scompensata, pre-/post-olt

Pazienti con Genotipo 1 e Cirrosi Scompensata, pre-/post-olt Monotematica AISF 2013 Pazienti con Genotipo 1 e Cirrosi Scompensata, pre-/post-olt Pietro Andreone Dipartimento di Scienze Mediche e Chirurgiche Alma Mater Studiorum, Università di Bologna Pisa, 17-19

More information

Liver transplant: what is left after the viruses

Liver transplant: what is left after the viruses Riunione Monotematica A.I.S.F. 2016 The Future of Liver Disease: Beyond HCV is there a Role for Hepatologist? Milan 15 th 2016 Liver transplant: what is left after the viruses Stefano Ginanni Corradini

More information

Alcoholic Liver Disease as First Indication

Alcoholic Liver Disease as First Indication Alcoholic Liver Disease as First Indication Patrizia Burra Multivisceral Transplant Unit Gastroenterology Department of Surgery, Oncology and Gastroenterology Padua University Hospital, Padua, Italy Patrizia

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function tests / tests of

More information

Towards Precision Medicine in Primary Biliary Cholangitis

Towards Precision Medicine in Primary Biliary Cholangitis Riunione Monotematica A.I.S.F. 2016 THE FUTURE OF LIVER DISEASES: Beyond HCV is there a role for the hepatologist? 14 th October 2016 Towards Precision Medicine in Primary Biliary Cholangitis Marco Carbone,

More information

Management of acute alcoholic hepatitis

Management of acute alcoholic hepatitis Management of acute alcoholic hepatitis Yesim ALAHDAB Marmara University Hospital, Istanbul/TURKEY 5 th European Young Hepatologists Workshop August, 27-29, 2015 Moulin de Vernègues, France 1.4L ALCOHOL

More information

Optimal management of ascites

Optimal management of ascites Optimal management of ascites P. Angeli, Dept. of Medicine, Unit of Internal Medicine and epatology (), University of Padova (Italy) pangeli@unipd.it 10th Paris epatology Conference National Conference

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function / liver function

More information

A case of acute liver failure in HIV/HBV co-infection

A case of acute liver failure in HIV/HBV co-infection A case of acute liver failure in HIV/HBV co-infection Lukun zhang Department of Infectious Disease The Third People s Hospital of Shenzhen May 12th,2017 History of present illness Patient basic information

More information

Hepatocellular carcinoma: Intra-arterial treatments

Hepatocellular carcinoma: Intra-arterial treatments Hepatocellular carcinoma: Intra-arterial treatments Irene Bargellini U.O. Radiologia Interventistica Azienda Ospedaliero Universitaria Pisana IRENE BARGELLINI,MD UO RADIOLOGIA INTERVENTISTICA, AZIENDA

More information

Complication of Portal Hypertension: should the patients in the waiting list be treated differently?

Complication of Portal Hypertension: should the patients in the waiting list be treated differently? Wilma Debernardi Venon Gastroepatologia, Az. Osp. San Giovanni Battista ditorino Complication of Portal Hypertension: should the patients in the waiting list be treated differently? Il sottoscritto dichiara

More information

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust The Yellow Patient Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust there s a yellow patient in bed 40. It s one of yours. Liver Cirrhosis Why.When.What.etc.

More information

World Health Organization. Western Pacific Region

World Health Organization. Western Pacific Region Basic modules for hepatitis 1 Basic Module 1 Liver anatomy and physiology 2 Position of liver Midline Located in right upper abdomen Protected by the right rib cage Right upper Measures: 12 15 cm in vertical

More information

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob: Hepatitis Dr. Mohamed. A. Mahdi Mob: 0123002800 5/2/2019 Hepatitis Hepatitis means the inflammation of the liver. May cause by viruses or bacteria, parasites, radiation, drugs, chemical and toxins (alcohol).

More information

Pierluigi Toniutto Clinica di Medicina Interna Azienda Ospedaliero Universitaria Udine

Pierluigi Toniutto Clinica di Medicina Interna Azienda Ospedaliero Universitaria Udine Pierluigi Toniutto Clinica di Medicina Interna Azienda Ospedaliero Universitaria Udine Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d interesse in relazione a questa presentazione

More information

Chronic Hepatic Disease

Chronic Hepatic Disease Chronic Hepatic Disease 10 th Leading Cause of Death Liver Functions Energy Metabolism Protein Synthesis Solubilization, Transport, and Storage Protects and Clears drugs, damaged cells Causes of Liver

More information

Approach to the Patient with Liver Disease

Approach to the Patient with Liver Disease Approach to the Patient with Liver Disease Diagnosis of liver disease Careful history taking Physical examination Laboratory tests Radiologic examination and imaging studies Liver biopsy Liver diseases

More information

Invasive Evaluation of Portal Hypertension. Vincenzo La Mura, MD PhD Department of Biomedical Sciences for Health University of Milan

Invasive Evaluation of Portal Hypertension. Vincenzo La Mura, MD PhD Department of Biomedical Sciences for Health University of Milan Invasive Evaluation of Portal Hypertension Vincenzo La Mura, MD PhD Department of Biomedical Sciences for Health University of Milan Vincenzo La Mura, MD, PhD Dipartimento di scienze Biomediche per la

More information

Riunione Monotematica AISF 2017 Roma 5 Ottobre Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease

Riunione Monotematica AISF 2017 Roma 5 Ottobre Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease Riunione Monotematica AISF 2017 Roma 5 Ottobre 2017 Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease Lorenzo Leggio, M.D., Ph.D., M.Sc. Lorenzo Leggio, M.D., Ph.D., M.Sc. Il

More information

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:

More information

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC : An Approach to Infectious and Other Causes Mary Anne Cooper MSc, MD, MEd, FRCPC Faculty: Dr. Mary Anne Cooper Relationships with commercial interests: Consulting Fees: Lupin Pharmaceuticals, Canada Objectives

More information

TIPS in the Management of Portal Hypertension Clinician s Opinion

TIPS in the Management of Portal Hypertension Clinician s Opinion TIPS in the Management of Portal Hypertension Clinician s Opinion Oliviero Riggio 5 th AISF post meeting course Diagnostic and Therapeutic Procedures in Hepatology 2012 Oliviero Riggio Dipartimento di

More information

Alcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD

Alcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD Alcoholic Hepatitis: Routine Screening for Early Recognition and Management Juan Guerrero, MD Global Problem 1% of GNP of medium/high income countries Additional societal costs Disproportionately affects

More information

Role of Nutritional Support in the Treatment of Alcoholic Liver Disease

Role of Nutritional Support in the Treatment of Alcoholic Liver Disease Riunione Monotematica AISF Alcoholic Liver Disease: The New Challenge Roma, 4-6 Ottobre 2017 Role of Nutritional Support in the Treatment of Alcoholic Liver Disease Esmeralda Capristo Divisione di Patologie

More information

EVALUATION OF ABNORMAL LIVER TESTS

EVALUATION OF ABNORMAL LIVER TESTS EVALUATION OF ABNORMAL LIVER TESTS MIA MANABAT DO PGY6 MOA 119 TH ANNUAL SPRING SCIENTIFIC CONVENTION MAY 19, 2018 EVALUATION OF ABNORMAL LIVER TESTS Review of liver enzymes vs liver function tests Clinical

More information

MEDIC CENTER. Case 2

MEDIC CENTER. Case 2 Case 2 Case history 57 year old Vietnamese man He lives in HCM city and works as a engineer The patient presented in July 2012 with fatigue Diagnosed with HCV in 2004 Negative for both HBV and HIV antibodies

More information

Optimal management of auto-immune

Optimal management of auto-immune collaborations des équipes impliquées dans l' explorati en charge des ef ets indésirables des immunothérapies INSCRIPTIONS BLIC : cialistes d organe, Chercheur s, ovigilants ns l es toxicités es anti-cancéreuses.

More information

Weight loss, Night sweats & Diarrhea Imported from the Ukraine Dr. Yael Weintraub Pediatric Gastroenterology Unit Dana-Dwek Children s Hospital

Weight loss, Night sweats & Diarrhea Imported from the Ukraine Dr. Yael Weintraub Pediatric Gastroenterology Unit Dana-Dwek Children s Hospital Weight loss, Night sweats & Diarrhea Imported from the Ukraine Dr. Yael Weintraub Pediatric Gastroenterology Unit Dana-Dwek Children s Hospital A.N,, 14 y.o., generally healthy, Ukraine citizen. Admitted

More information

A Rational Evidence-based Approach to Abnormal Liver Tests

A Rational Evidence-based Approach to Abnormal Liver Tests A Rational Evidence-based Approach to Abnormal Liver Tests Jane D. Ricaforte-Campos, MD FPCP, FPSG, FPSDE 2013 HSP Post-graduate Course Radisson Blu Hotel, Cebu City misnomer Liver Function Tests Does

More information

CLIF Consortium. Protocol of the CLIF Acute-oN-ChrONic LIver Failure in Cirrhosis (CANONIC) Core Study

CLIF Consortium. Protocol of the CLIF Acute-oN-ChrONic LIver Failure in Cirrhosis (CANONIC) Core Study CLIF Consortium Protocol of the CLIF Acute-oN-ChrONic LIver Failure in Cirrhosis (CANONIC) Core Study Case Report Form (Final) Center: Investigator: Investigator s Signature: The highlighted information

More information

Colangiocarcinoma on the rise!

Colangiocarcinoma on the rise! Colangiocarcinoma on the rise! D. ALVARO, Univ. Sapienza, Rome, Italy. MONOTEMATICA AISF, The future of Liver Diseases, Milano 13-15 Ottobre 2016 Domenico ALVARO, MD. SAPIENZA, ROMA Il sottoscritto dichiara

More information

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver A Review of Liver Function Tests James Gray Gastroenterology Vancouver Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

Staging and prognostic systems: beyond BCLC?

Staging and prognostic systems: beyond BCLC? Staging and prognostic systems: beyond BCLC? Alessandro Vitale, MD, PhD, FEBS U.O.C. di Chirurgia Epatobiliare e dei Trapianti Epatici, Department of Surgery, Oncology and Gastroenterology, University

More information

Management of the Cirrhotic Patient in the ICU

Management of the Cirrhotic Patient in the ICU Management of the Cirrhotic Patient in the ICU Peter E. Morris, MD Professor & Chief, Pulmonary, Critical Care and Sleep Medicine University of Kentucky Conflict of Interest Funding US National Institutes

More information

Clinical Case Maria Butí, MD, PhD

Clinical Case Maria Butí, MD, PhD Clinical Case Maria Butí, MD, PhD Liver Unit, Internal Medicine Department Vall d Hebron Hospital 1 Clinical Case 70 year-old male Smoker, no alcohol intake No risk factors Diabetes Mellitus treated with

More information

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob: Diseases of liver Dr. Mohamed. A. Mahdi Mob: 0123002800 4/2/2019 Cirrhosis Cirrhosis is a complication of many liver disease. Permanent scarring of the liver. A late-stage liver disease. The inflammation

More information

Autoimmune Hepatitis. Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern. November 14th, 2018

Autoimmune Hepatitis. Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern. November 14th, 2018 Autoimmune Hepatitis Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern November 14th, 2018 AIH - Definition Manns MP J Hepatol 2015, vol 62, P 100-111 AIH - Definition Autoimmune hepatitis (AIH) is

More information

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust ABNORMAL LIVER FUNCTION TESTS Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust INTRODUCTION Liver function tests Cases Non invasive fibrosis measurement Questions UK MORTALITY RATE

More information

Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L.

Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L. Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity Alessandro Federico University of Campania L. Vanvitelli Alessandro Federico Markers of Alcohol Abuse in Alcoholic Liver

More information

Alcoholic Hepatitis: Management Options

Alcoholic Hepatitis: Management Options Alcoholic Hepatitis: Management Options Paul J. Thuluvath, MD. FRCP Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore Professor of Surgery & Medicine, Georgetown University,

More information

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France Management of autoimmune hepatitis Pierre-Emmanuel RAUTOU Inserm U970, PARCC@HEGP, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France 41 year-old woman, coming to emergency department for fatigue

More information

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Terminology Acute decompensation of cirrhosis - stable patient with sudden deterioration Acute-on-chronic liver failure

More information

Patient Encounters in the Primary Care Setting

Patient Encounters in the Primary Care Setting Patient Encounters in the Primary Care Setting Carmine D Amico, D.O. Clinical Cases Overview Learning objectives Clinical case presentations Questions for audience participation 1 Clinical Cases Learning

More information

Alzheimer s Disease, Dementia, Related Disorders

Alzheimer s Disease, Dementia, Related Disorders Alzheimer s Disease, Dementia, Related Disorders Stage 7 on the FAST Scale signifies the threshold of activity limitation that would support a six-month prognosis. The FAST Scale does not address the impact

More information

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology

More information

Umberto Volta Coeliac Disease and Malbsorption Unit Digestive Diseases and Internal Medicine Dept St.Orsola-Malpighi Hospital, Bologna

Umberto Volta Coeliac Disease and Malbsorption Unit Digestive Diseases and Internal Medicine Dept St.Orsola-Malpighi Hospital, Bologna Coeliac disease Umberto Volta Coeliac Disease and Malabsorption Unit Digestive Diseases and Internal Medicine Dept. St. Orsola-Malpighi Hospital University of Bologna President of the Scientific Board

More information

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS

More information

Module 1 Introduction of hepatitis

Module 1 Introduction of hepatitis Module 1 Introduction of hepatitis 1 Training Objectives At the end of the module, trainees will be able to ; Demonstrate improved knowledge of the global epidemiology of the viral hepatitis Understand

More information

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes

More information

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune hepatobiliary diseases The liver is an important target for immunemediated injury. Three disease phenotypes are recognized:

More information

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,

More information

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications

More information

Management of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran

Management of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran Management of Alcoholic Liver Disease Hafez Fakheri Professor of medicine, Sari, Iran Alcoholic Hepatitis Scores DF = (4.6 x [ PT- control PT]) + (bili ) MELD = 10 * ((0.957 * ln(cr)) + (0.378 * ln(bil))

More information

Chief infectionist of Kirov region Head of department in Kirov ID Hospital

Chief infectionist of Kirov region Head of department in Kirov ID Hospital Clinical case Elena Tikhomolova, MD Chief infectionist of Kirov region Head of department in Kirov ID Hospital First referred for consultation in Sep 2014 Symptoms include: fatigue dizziness pruritis sleep

More information

Case report Fever in a patient with ANCA-associated vasculitis

Case report Fever in a patient with ANCA-associated vasculitis Case report Fever in a patient with ANCA-associated vasculitis 73 years-old white woman PRIOR MEDICAL HISTORY *Hypertension: Enalapril, Furosemide *Dyslipidemia: Pravastatin *Ischemic heart disease: 2008

More information

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians Slide 1 of 32 End-Stage Liver Disease (ESLD): A Guide for HIV Physicians Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California

More information

Tables of Normal Values (As of February 2005)

Tables of Normal Values (As of February 2005) Tables of Normal Values (As of February 2005) Note: Values and units of measurement listed in these Tables are derived from several resources. Substantial variation exists in the ranges quoted as normal

More information

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Acute Liver Failure Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Disclosures None Outline Overview of ALF Management of ALF Diagnosis of ALF Treatments and Support

More information

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for: Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona

More information

The Use of Tests in Clinical Biochemistry Interpreting Blood Results. Rowland Reece Principal Clinical Biochemist St. Vincent s University Hospital

The Use of Tests in Clinical Biochemistry Interpreting Blood Results. Rowland Reece Principal Clinical Biochemist St. Vincent s University Hospital The Use of Tests in Clinical Biochemistry Interpreting Blood Results Rowland Reece Principal Clinical Biochemist St. Vincent s University Hospital Topic Headlines What is Clinical Biochemistry? How does

More information

Mr. I.K 58 years old

Mr. I.K 58 years old Mr. I.K 58 years old Hospitalized because of marked pitting peripheral edema (bilateral crural and perimalleolar edema) and uncontrolled blood pressure (BP 150/100 mmhg under treatment). since age 54 years

More information

Case conference. Welcome Dr. Lawrence Tierney

Case conference. Welcome Dr. Lawrence Tierney Case conference Welcome Dr. Lawrence Tierney Case: 18 year-old male CC) hamatomesis, Fever and cough HPI) 1 st admission One month ago, he admitted to our hospital because of hematemesis. He had weight

More information

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Patrick Northup, MD, FAASLD, FACG Medical Director, Liver Transplantation University of Virginia

More information

THAI J GASTROENTEROL 2014 Vol. 15 No May - Aug. 2014

THAI J GASTROENTEROL 2014 Vol. 15 No May - Aug. 2014 Case Report Poovorawan K, et al. 105 Fatal Acute-on-Chronic Liver Failure from Amiodarone Toxicity Poovorawan K 1,2 Wisedopas N 3 Treeprasertsuk S 1 Komolmit P 1 ABSTRACT Background: Drug induced liver

More information

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon

More information

molecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011

molecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011 molecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011 Case Vignette A 25-year old man was admitted to our hospital because of fever, productive cough, nausea and weight loss. The patient had

More information

Norepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome

Norepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome Norepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome Disclosure I have no conflicts of interest to disclose Name: Margarita Taburyanskaya Title: PharmD, PGY1 Pharmacy Practice Resident

More information

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,

More information

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use. LIVER CIRRHOSIS William Sanchez, M.D. & Jayant A. Talwalkar, M.D., M.P.H. Advanced Liver Disease Study Group Miles and Shirley Fiterman Center for Digestive Diseases Mayo College of Medicine Rochester,

More information

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015 ESLD a Guide for HIV Physicians Marion Peters University of California San Francisco June 2015 Disclosures Honararia from Johnson and Johnson Roche Merck Gilead Spouse employee of Hoffman La Roche Natural

More information

MEMORANDUM. These reference ranges are effective immediately but sample requirements remain unchanged currently.

MEMORANDUM. These reference ranges are effective immediately but sample requirements remain unchanged currently. MEMORANDUM Originating Department Chemical Pathology Issued By: Issued To: Subject: Details: Dr. Shari Srinivasan All Laboratory Service Users Change in Chemical Pathology Analysers Dear Colleague, As

More information

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I

More information

GASTROENTEROLOGY ESSENTIALS

GASTROENTEROLOGY ESSENTIALS GASTROENTEROLOGY ESSENTIALS Practical Gastroenterology 8/25/2018 Jahnavi Koppala, MBBS Abdullah Abdussalam, MD A 48-year-old male was evaluated for noncardiac chest pain. Treatment with PPI twice daily

More information

JOURNAL PRESENTATION. Dr Tina Fan Tseung Kwan O Hospital 17 th Jan 2013

JOURNAL PRESENTATION. Dr Tina Fan Tseung Kwan O Hospital 17 th Jan 2013 JOURNAL PRESENTATION Dr Tina Fan Tseung Kwan O Hospital 17 th Jan 2013 THE COMBINATION OF OCTREOTIDE AND MIDODRINE IS NOT SUPERIOR TO ALBUMIN IN PREVENTING RECURRENCE OF ASCITES AFTER LARGE-VOLUME PARACENTESIS

More information

Assessment of Liver Function: Implications for HCC Treatment

Assessment of Liver Function: Implications for HCC Treatment Assessment of Liver Function: Implications for HCC Treatment A/P Dan Yock Young MBBS, PhD, MRCP, MMed. FAMS Chair, University Medicine Cluster. NUHS Head, Department of Medicine, National University of

More information

Hepatitis C: How sick can we treat? Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of

Hepatitis C: How sick can we treat? Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Hepatitis C: How sick can we treat? Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Gastroenterology & Hepatology www.livermd.org HCV in advanced disease In principle

More information

Available online at

Available online at Available online at www.annclinlabsci.org 96 Case Report: Hepatorenal Syndrome: Resolution of Ascites by Continuous Renal Replacement Thera py in an Alcoholic Coinfe cted with Hepatitis B, C, and Human

More information

Hepatology cases for the generalist. Will Gelson Consultant Hepatologist Addenbrooke s Hospital

Hepatology cases for the generalist. Will Gelson Consultant Hepatologist Addenbrooke s Hospital Hepatology cases for the generalist Will Gelson Consultant Hepatologist Addenbrooke s Hospital 30 y o man with upper GI haemorrhage Background heavy alcohol use Hxof 3 pint haematemesis P 100, BP 90/40,

More information

Evaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA

Evaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA Evaluating HIV Patient for Liver Transplantation Marion G. Peters, MD Professor of Medicine University of California San Francisco USA Slide 2 ESLD and HIV Liver disease has become a major cause of death

More information

58 Year-old Male with Alcoholic Cirrhosis Presents with Hyponatremia. Jess Hwang 11/8/12

58 Year-old Male with Alcoholic Cirrhosis Presents with Hyponatremia. Jess Hwang 11/8/12 58 Year-old Male with Alcoholic Cirrhosis Presents with Hyponatremia Jess Hwang 11/8/12 HPI Fluid leaking from umbilical hernia secondary to his ascites Went to OR for drain placement which was complicated

More information

A 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary

A 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary A 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary A 73 year old man PS presents with anaemia. Endoscopy and CT scan thorax/abdomen

More information

GI bleeding in chronic liver disease

GI bleeding in chronic liver disease GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old

More information

INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS

INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS Yoshida H et al (1993)* Deschenes M et al (1999)** Strauss E et al (1993) Borzio M et al (2002) PATIENTS 1140 140 170 405 INFECTIONS 15.4% 20% 47% 34% * Many

More information

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO Selection Examination for Enrolment to the in-service Training Programme in Postgraduate Certificate in Basic Laboratory Sciences leading to the

More information

Discharge Summary-Page 1

Discharge Summary-Page 1 Discharge Summary-Page 1 Admission diagnosis: 1. Gastritis. 2. Alcoholic cirrhosis, ascites, grade 1 esophageal varices. 3. Recent left knee arthroplasty. 4. Osteoporosis naqmq : 1. Three chest X-rays

More information

Trapianto di fegato e organi solidi. Pierluigi Toniutto Sezione di Epatologia e Trapianto Epatico Università di Udine

Trapianto di fegato e organi solidi. Pierluigi Toniutto Sezione di Epatologia e Trapianto Epatico Università di Udine Trapianto di fegato e organi solidi Pierluigi Toniutto Sezione di Epatologia e Trapianto Epatico Università di Udine Case 1 55-yr old white woman Alcoholic cirrhosis (CTP score 11, MELD 24, status UNOS

More information

The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio

The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist K V Speeg, MD, PhD UT Health San Antonio Objectives Review staging of liver disease Review consequences of end-stage

More information

Liver failure &portal hypertension

Liver failure &portal hypertension Liver failure &portal hypertension Objectives: by the end of this lecture each student should be able to : Diagnose liver failure (acute or chronic) List the causes of acute liver failure Diagnose and

More information

Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:

Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if: Supplemental Appendix 1. Protocol Definition of Sustained Virologic Response A patient has a sustained virologic response if: 1. The patient is a responder at the end of treatment and all subsequent planned

More information

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Ashwani K. Singal, MD, MS, FACG 1, Ramon Bataller, MD, PhD, FACG 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick S. Kamath,

More information

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry MPharm Programme Liver Biochemistry Slide 1 of 49 MPHM Liver Biochemistry Learning Outcomes Assess and evaluate the signs and symptoms of illness Assess and critically appraise a patients medication regimen,

More information

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT 44 Original Article Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Jaroon Chasawat Varayu Prachayakul Supot Pongprasobchai ABSTRACT Background: Upper gastrointestinal bleeding (UGIB)

More information

Management of Cirrhosis Related Complications

Management of Cirrhosis Related Complications Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this

More information

Hepatitis C Virus (HCV)

Hepatitis C Virus (HCV) Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are

More information

CHAPTER 1. Alcoholic Liver Disease

CHAPTER 1. Alcoholic Liver Disease CHAPTER 1 Alcoholic Liver Disease Major Lesions of Alcoholic Liver Disease Alcoholic fatty liver - >90% of binge and chronic drinkers Alcoholic hepatitis precursor of cirrhosis Alcoholic cirrhosis end

More information

Liver Disease. By: Michael Martins

Liver Disease. By: Michael Martins Liver Disease By: Michael Martins Recently I have been getting a flurry of patients that have some serious liver complications. This week s literature review will be the dental management of the patients

More information